filmov
tv
Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett’s ...
Показать описание
Noam Peleg on " Neutrophil to lymphocyte ratio and risk of neoplastic progression in patients with Barrett’s esophagus"
Authors: Noam Peleg, Hemda Schmilovitz-Weiss, Steven Shamah et al.
Summary:
An analysis in 324 individuals with Barrett’s esophagus showed that a simple inflammation marker, the peripheral blood neutrophil to lymphocyte ratio (NLR), was predictive of progression to neoplasia. In particular, an NLR above 2.4 was associated with a 3-fold increase in progression to high grade dysplasia or adenocarcinoma during follow-up. This finding was consistent even in patients with nondysplastic
Barrett’s esophagus at baseline.
Bibliography
Endoscopy 2021; 53: 774–781
DOI 10.1055/a-1292-8747
ISSN 0013-726X
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG, Rüdigerstraße 14,
70469 Stuttgart, Germany
Authors: Noam Peleg, Hemda Schmilovitz-Weiss, Steven Shamah et al.
Summary:
An analysis in 324 individuals with Barrett’s esophagus showed that a simple inflammation marker, the peripheral blood neutrophil to lymphocyte ratio (NLR), was predictive of progression to neoplasia. In particular, an NLR above 2.4 was associated with a 3-fold increase in progression to high grade dysplasia or adenocarcinoma during follow-up. This finding was consistent even in patients with nondysplastic
Barrett’s esophagus at baseline.
Bibliography
Endoscopy 2021; 53: 774–781
DOI 10.1055/a-1292-8747
ISSN 0013-726X
© 2020. Thieme. All rights reserved.
Georg Thieme Verlag KG, Rüdigerstraße 14,
70469 Stuttgart, Germany
0:02:14
0:02:08
0:01:09
0:00:54
0:30:06
0:10:52
0:07:12
0:01:14
0:01:12
0:16:05
0:03:36
0:01:57
0:00:25
0:02:51
0:04:15
0:09:52
0:04:32
1:00:20
0:00:52
0:00:50
0:01:12
1:01:52
0:13:18
0:01:18